CLINICAL RESEARCH: CONGENITAL HEART DISEASE
Early and Late Results of the Modified Fontan Operation for Heterotaxy Syndrome
30 Years of Experience in 142 Patients
Peter J. Bartz, MD*,
David J. Driscoll, MD*, ,
Joseph A. Dearani, MD ,
Francisco J. Puga, MD,
Gordon K. Danielson, MD,
Patrick W. O'Leary, MD*,
Michael G. Earing, MD*,
Carole A. Warnes, MD*,,
David O. Hodge, MS and
Frank Cetta, MD*,,*
* Pediatric Cardiology
Cardiovascular Diseases and Internal Medicine
Department of Thoracic and Cardiovascular Surgery
Section of Biostatistics, Mayo Clinic College of Medicine, Rochester, Minnesota
Manuscript received March 20, 2006;
revised manuscript received June 23, 2006,
accepted July 3, 2006.
* Reprint requests and correspondence: Dr. Frank Cetta, Division of Pediatric Cardiology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, Minnesota 55905. (Email: cetta.frank{at}mayo.edu).
OBJECTIVES: We sought to evaluate the early and late results of the modified Fontan operation for patients with heterotaxy syndrome, assess variables traditionally known to correlate with poor outcome, and assess current health status of survivors after the Fontan procedure.
BACKGROUND: The natural history of unoperated cardiac lesions in heterotaxy is known to be poor. Therefore, the Fontan operation has been proposed to improve survival.
METHODS: Patients with heterotaxy were identified from the Mayo Clinic Fontan database. Hospital and outpatient records were abstracted for preoperative, operative, and postoperative clinical and hemodynamic data. All patients not known to be deceased were sent health status questionnaires.
RESULTS: A total of 142 patients with heterotaxy syndrome had a modified Fontan operation. Asplenia was present in 76 patients (54%). Median age at operation was 9 years (range 2 to 35 years). Median follow-up was 4 years (range 0 to 23 years). There were a total of 61 deaths (43%), with 32 (23%) within 30 days of operation or before hospital discharge. The 5-, 10-, and 15-year survival was 64%, 57%, and 53%, respectively. In the modern era (1995 to 2004) early mortality was 10%. Of the 81 survivors, questionnaires were available from 41 (51%). Eighty percent reported having no or mild symptoms. However, 19 (46%) had arrhythmias, 5 (12%) had a thromboembolic event, and 1 (2%) developed protein-losing enteropathy.
CONCLUSIONS: Early survival has improved for heterotaxy patients after the Fontan operation; however, late morbidity and mortality remain substantial. Better strategies for long-term treatment of this high-risk group need to be identified.
|
Abbreviations and Acronyms
| | AV = atrioventricular | | IVC = inferior vena cava | | SVC = superior vena cava |
|
This article has been cited by other articles:
|
|
|
|
 
H. Ohuchi, K. Kagisaki, A. Miyazaki, M. Kitano, S. Yazaki, H. Sakaguchi, H. Ichikawa, O. Yamada, and T. Yagihara
Impact of the Evolution of the Fontan Operation on Early and Late Mortality: A Single-Center Experience of 405 Patients Over 3 Decades
Ann. Thorac. Surg.,
October 1, 2011;
92(4):
1457 - 1466.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Perry, M. Lanzberg, W. Franklin, G. Webb, and A. C. Chang
Cardiac Intensive Care of the Adult With Congenital Heart Disease: Basic Principles in the Management of Common Problems
World Journal for Pediatric and Congenital Heart Surgery,
July 1, 2011;
2(3):
430 - 444.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. A. Jonas
Surgical Management of the Neonate With Heterotaxy and Long-Term Outcomes of Heterotaxy
World Journal for Pediatric and Congenital Heart Surgery,
April 1, 2011;
2(2):
264 - 274.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. A. Yurlov, V. P. Podzolkov, M. M. Zelenikin, D. V. Kovalev, G. K. Babaev, N. A. Putiato, and S. B. Zaets
Experience with bidirectional cavopulmonary anastomosis and modified Fontan operation in patients with single ventricle and concomitant visceral heterotaxy
Interact CardioVasc Thorac Surg,
April 1, 2011;
12(4):
563 - 568.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Swisher, R. Jonas, X. Tian, E. S. Lee, C. W. Lo, and L. Leatherbury
Increased postoperative and respiratory complications in patients with congenital heart disease associated with heterotaxy
J. Thorac. Cardiovasc. Surg.,
March 1, 2011;
141(3):
637 - 644.e3.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. S. Burstein, C. Mavroudis, M. D. Puchalski, R. D. Stewart, C. J. Blanco, and M. L. Jacobs
Pulmonary Arteriovenous Malformations in Heterotaxy Syndrome: The Case for Early, Direct Hepatic Vein-to-Azygos Vein Connection
World Journal for Pediatric and Congenital Heart Surgery,
January 1, 2011;
2(1):
119 - 128.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. G. Quinonez, M. L. Brown, J. A. Dearani, H. M. Burkhart, and F. J. Puga
Axillary arteriovenous fistula for the palliation of complex cyanotic congenital heart disease: Is it an effective tool?
J. Thorac. Cardiovasc. Surg.,
January 1, 2011;
141(1):
188 - 192.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Serraf, N. Bensari, L. Houyel, A. Capderou, R. Roussin, E. Lebret, M. Ly, and E. Belli
Surgical management of congenital heart defects associated with heterotaxy syndrome
Eur J Cardiothorac Surg,
December 1, 2010;
38(6):
721 - 727.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A.-M. Tan, A. J. Iyengar, S. Donath, A. M. Bullock, G. Wheaton, L. Grigg, C. P. Brizard, and Y. d'Udekem
Fontan completion rate and outcomes after bidirectional cavo-pulmonary shunt
Eur J Cardiothorac Surg,
July 1, 2010;
38(1):
59 - 65.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Vodiskar, S.-A. Clur, J. Hruda, R. Bokenkamp, and M. G. Hazekamp
Left atrial isomerism: biventricular repair
Eur J Cardiothorac Surg,
June 1, 2010;
37(6):
1259 - 1263.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Nakata, Y. Fujimoto, K. Hirose, M. Osaki, Y. Tosaka, Y. Ide, M. Tachi, and K. Sakamoto
Fontan completion in patients with atrial isomerism and separate hepatic venous drainage
Eur J Cardiothorac Surg,
June 1, 2010;
37(6):
1264 - 1270.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Naito, M. Aoki, K. Matsuo, H. Nakajima, H. Aotsuka, and T. Fujiwara
Intracardiac Fontan procedure for heterotaxy syndrome with complex systemic and pulmonary venous anomalies
Eur J Cardiothorac Surg,
January 1, 2010;
37(1):
197 - 203.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Prakash, M. A. Khan, R. Hardy, A. J. Torres, J. M. Chen, and W. M. Gersony
A new diagnostic algorithm for assessment of patients with single ventricle before a Fontan operation
J. Thorac. Cardiovasc. Surg.,
October 1, 2009;
138(4):
917 - 923.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. V. Anagnostopoulos, J. M. Pearl, C. Octave, M. Cohen, A. Gruessner, E. Wintering, and M. F. Teodori
Improved current era outcomes in patients with heterotaxy syndromes
Eur J Cardiothorac Surg,
May 1, 2009;
35(5):
871 - 878.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H.G. Lim, E.A. Bacha, G.R. Marx, A. Marshall, F. Fynn-Thompson, J.E. Mayer, P. Del Nido, and F.A. Pigula
Biventricular repair in patients with heterotaxy syndrome.
J. Thorac. Cardiovasc. Surg.,
February 1, 2009;
137(2):
371 - 379.e3.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Agematsu, Y. Naito, M. Aoki, and T. Fujiwara
Total cavo-pulmonary connection without foreign material for asplenic heart associated with partial anomalous pulmonary venous connection
Interact CardioVasc Thorac Surg,
April 1, 2008;
7(2):
344 - 346.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Khairy, S. M. Fernandes, J. E. Mayer Jr, J. K. Triedman, E. P. Walsh, J. E. Lock, and M. J. Landzberg
Long-Term Survival, Modes of Death, and Predictors of Mortality in Patients With Fontan Surgery
Circulation,
January 1, 2008;
117(1):
85 - 92.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
